|
Volumn 47, Issue SUPPL. 3, 2011, Pages
|
Geriatrics and haematological malignancies: Is comprehensive geriatric assessment a useful tool?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZACITIDINE;
LENALIDOMIDE;
MONOCLONAL ANTIBODY;
OFATUMOMAB;
PANOBINOSTAT;
POMALIDOMIDE;
PONATINIB;
UNCLASSIFIED DRUG;
ACUTE GRANULOCYTIC LEUKEMIA;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CLINICAL ASSESSMENT;
CLINICAL ASSESSMENT TOOL;
CLINICAL DECISION MAKING;
COMORBIDITY;
COMPREHENSIVE GERIATRIC ASSESSMENT;
GERIATRIC CARE;
GERIATRICS;
HEMATOLOGIC MALIGNANCY;
HUMAN;
INCIDENCE;
INTERNATIONAL PROGNOSTIC SCORING SYSTEM;
LIFE EXPECTANCY;
MDS SPECIFIC COMORBIDITY INDEX;
MINI MENTAL STATE EXAMINATION;
MULTIPLE MYELOMA;
MYELODYSPLASTIC SYNDROME;
NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES;
NONHODGKIN LYMPHOMA;
OUTCOME ASSESSMENT;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROGNOSIS;
RISK ASSESSMENT;
AGED;
AGED, 80 AND OVER;
COMPREHENSIVE HEALTH CARE;
GERIATRIC ASSESSMENT;
GERIATRICS;
HEMATOLOGIC NEOPLASMS;
HUMANS;
PREDICTIVE VALUE OF TESTS;
|
EID: 80053281445
PISSN: 09598049
EISSN: 18790852
Source Type: Journal
DOI: 10.1016/S0959-8049(11)70204-0 Document Type: Article |
Times cited : (2)
|
References (7)
|